Align Capital Partners Recapitalizes Premier Biotech

Premier Biotech Acquires National Test Systems

November 5, 2025

Medical Devices

Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.

Align Capital Partners Recapitalizes Cleartelligence

January 5, 2023

Data & Analytics

Align Capital Partners (ACP) completed a recapitalization of Cleartelligence, a Newton, Massachusetts–based data engineering and analytics consulting firm. The deal keeps the company’s founders and existing management as significant investors while providing capital and resources to accelerate growth, expand services and pursue strategic add‑on acquisitions.

Patient Square Capital Acquires Premier, Inc.

November 25, 2025

Healthcare Services

Patient Square Capital, a healthcare-focused investment firm, has completed its $2.6 billion acquisition of Premier, Inc. Under the deal, Premier will be taken private, delisted from Nasdaq, and Premier stockholders will receive $28.25 per share in cash. The transaction positions Patient Square to grow Premier's technology-driven data, analytics, supply chain and consulting offerings.

Patient Square Capital Acquires Premier, Inc.

November 25, 2025

Healthcare Services

Patient Square Capital, a healthcare-focused private equity firm, is acquiring Premier, Inc. in a take-private transaction approved by Premier stockholders. Under the deal Premier stockholders will receive $28.25 per share (a ~23.8% premium) and the transaction — valued at roughly $2.6 billion — was expected to close on or about November 25, 2025.

Prairie Capital Recapitalizes Kashi Clinical Laboratories

June 20, 2024

Healthcare Services

Prairie Capital partnered with founder Dr. Zahra Kashi and senior management to recapitalize Kashi Clinical Laboratories, a Portland, Oregon-based accredited clinical laboratory specializing in HLA typing, post-transplant monitoring, genomic sequencing and diagnostic testing. Prairie will support accelerated growth through investments in human capital, sales & marketing, technology and infrastructure, as well as pursuing add-on acquisitions.

Bridgepoint Development Capital Recapitalizes Prescient Healthcare Group

January 21, 2021

Healthcare Services

Bridgepoint Development Capital led a recapitalization of Prescient Healthcare Group, a London-based product strategy consultancy serving the global biopharmaceutical industry; the transaction closed January 19, 2021. Baird Capital (the exiting majority investor) provided a full exit but reinvested as a minority shareholder alongside Bridgepoint to support Prescient's next phase of growth and international expansion.